US Patent Issued on May 26 for "Treatment of inflammation initiated by the spinal cord injury, the traumatic brain injury, stroke, in inhibition of cerebral and spinal cord edema and of inflammation in neurodegenerative, immune mediated and infectious diseases of the central nervous system" (Canadian Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,261, issued on May 26.

"Treatment of inflammation initiated by the spinal cord injury, the traumatic brain injury, stroke, in inhibition of cerebral and spinal cord edema and of inflammation in neurodegenerative, immune mediated and infectious diseases of the central nervous system" was invented by Jacek M. Kwiecien (Hamilton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to the anti-inflammatory therapeutic effect of xantohumol in spinal cord injury (SCI). The continuous administration of xanthohumol for 1-8 weeks to SCI rats resulted in improved results in 4 clinical tests used and in lowering and faster elimi...